EMPLOYMENT AGREEMENTEmployment Agreement • April 1st, 2002 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Colorado
THIS AGREEMENT (the "Agreement") is entered into effective as of this 1st day of October, 2001 (the "Effective Date"), by and between NaPro BioTherapeutics, Inc., a Delaware corporation (the "Company"), and Leonard P. Shaykin ("Executive"). Certain capitalized terms used in this Agreement have the meaning set forth in Paragraph 17 of this Agreement.
NaPro / Abbott Side Letter AgreementLetter Agreement • April 1st, 2002 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products
Reference is made to the Development and Supply Agreement of July 23, 1999 between Abbott Laboratories and NaPro BioTherapeutics (as amended to date, the "Development Agreement"); and the Release and License Agreement among Abbott, NaPro and Bristol-Myers Squibb Company (the "License Agreement.")
RELEASE AND LICENSE AGREEMENTRelease and License Agreement • April 1st, 2002 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • New York
This Release and License Agreement (this "Agreement") dated as of November 28, 2001 (the "Effective Date") is entered into by and among NaPro BioTherapeutics, Inc. ("NaPro"), a Delaware corporation with a principal office at 6304 Spine Road, Unit A, Boulder, Colorado, Abbott Laboratories ("Abbott"), an Illinois corporation with a principal office of 100 Abbott Park Road, Abbott Park, Illinois and Bristol-Myers Squibb Co. ("BMS"), a Delaware Corporation with a principal office at 345 Park Avenue, New York, New York. NaPro, Abbott and BMS are referred to herein collectively as the "Parties" and individually as a "Party".
